Skip to main navigation

Skip to Content

Overview
Stock Information
News & Events
Financials
- SEC Filings
- Quarterly Results
Governance
- Governance Highlights
- Committee Composition
Investor Resources

News Releases

Year

Mar 06, 2023

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Feb 28, 2023

HARMONY BIOSCIENCES CONTINUES COMMUNITY COMMITMENT IN 2023 WITH PATIENTS AT THE HEART AND PROGRESS AT THE HEART NONPROFIT FUNDING PROGRAMS

Feb 21, 2023

Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

Feb 17, 2023

HARMONY BIOSCIENCES CERTIFIED AS A GREAT PLACE TO WORK® FOR FIFTH CONSECUTIVE YEAR

Feb 07, 2023

HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 21, 2023

Jan 06, 2023

HARMONY BIOSCIENCES APPOINTS JEFFREY M. DAYNO, MD AS INTERIM CEO AND EXPANDS ROLE OF JEFF ARONIN TO EXECUTIVE CHAIRMAN

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Displaying 31 - 36 of 36

Site - Shareholder Tools

Copyright © 2023 Harmony Biosciences All rights reserved.

Facebook
Twitter
LinkedIn
Google+